Norton, MA, United States of America

Greg Smith

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 8.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Greg Smith - Innovator in Pharmaceutical Innovations

Introduction

Greg Smith, an accomplished inventor based in Norton, MA, has made significant contributions to the field of pharmaceuticals through his inventive spirit. With four patents to his name, Smith has demonstrated an unwavering commitment to innovation, particularly in the development of advanced drug formulations.

Latest Patents

Among his latest achievements, Greg Smith's groundbreaking patent for an Aripiprazole prodrug composition stands out. This composition involves a distinctive formulation that includes (a) a population of particles of an aripiprazole prodrug with a volume-based particle size (Dv50) of less than 1000 nm, and (b) at least one surface stabilizer. The stabilizer comprises an adsorbed component that is adhered to the surface of the aripiprazole prodrug particles, along with a free component that is available for solubilizing the prodrug. The optimized ratio of surface stabilizer to prodrug is crucial for creating a lead-in formulation, which holds the potential for efficient treatment methods using this composition.

Career Highlights

Greg Smith is currently associated with Alkermes Pharma Ireland Limited, where he continues to work on pioneering pharmaceutical technologies. His initiatives have not only contributed to the advancement of drug delivery systems but have also positioned him as a prominent figure in the industry focused on improving patient outcomes.

Collaborations

Throughout his career, Greg has collaborated with talented individuals such as Philip Cresswell and Magali B. Hickey. These partnerships have fostered an environment of creativity and innovation, allowing the team to push the boundaries of what is possible in pharmaceutical sciences.

Conclusion

In summary, Greg Smith exemplifies the role of a dedicated inventor in the pharmaceutical sector. His patents, particularly in the area of Aripiprazole prodrug compositions, highlight his contribution to meaningful advancements in medicine. With his collaborative efforts and continued focus on innovation, Smith is sure to remain a key player in the field of drug formulation and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…